Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
in response to
by
posted on
Apr 19, 2020 07:35PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi Bear,
I wonder if Zenith has pulled out of the virtual AACR conference completely,
it would shock me at all with no explanation